PAYVANDI, FLORA

PAYVANDI, FLORA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 829 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors 2024 Peyvandi, Flora + Article (author) -
Next-generation strategies to improve safety and efficacy of adeno-associated virus-based gene therapy for hemophilia: lessons from clinical trials in other gene therapies 2024 Peyvandi, Flora + Article (author) -
Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B 2024 Peyvandi, Flora + Article (author) -
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results 2024 Peyvandi, Flora + Article (author) -
Comprehensive investigation of platelet function in patients with cirrhosis 2024 Ghali, ClaudiaLa Mura, VincenzoLampertico, PietroPeyvandi, FloraTripodi, Armando + Article (author) -
Gene therapy for people with Haemophilia B: a proposed care delivery model in Italy 2024 La Mura, VincenzoPeyvandi, Flora + Article (author) -
Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19 2024 Gualtierotti, RobertaGiachi, AndreaMontano, NicolaFracanzani, Anna LudovicaBandera, AlessandraPeyvandi, Flora + Article (author) -
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial 2024 Peyvandi, FloraMancuso, Maria Elisa + Article (author) -
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 2024 A. LombardiS. VillaM. ColaneriG. ScaglioneF. BaiB. VariscoV. BonoG. VieroM. ManteroF. PeyvandiG. MarchettiA. GoriA. BanderaS. BosariL. ValentiD. MangioniR. UngaroV. CastelliE. PalombaC. A. PeriP. SaltiniV. PastoreA. LiparotiT. MuheberimanaA. GiommiC. BobbioR. GualtierottiE. PagliaroC. MassimoM. De CaroA. GiachiN. MontanoB. VigoneC. BellocchiA. CarandinaE. TobaldiniF. BlasiS. AlibertiM. SpottiL. TerranovaS. MisuracaM. ContariniL. MorlacchiA. GramegnaM. PappaletteraA. BuscemiM. VicenziG. CostantinoM. SolbiatiL. FurlanA. FaninM. PassarellaV. MonzaniF. BilliS. AccordinoD. MairaN. ScaramelliniA. L. FracanzaniR. LombardiA. CespiatiM. CesariM. ProiettiL. CalcaterraG. GrasselliS. Harari + Article (author) -
IgM autoantibodies to complement factor H in C3 glomerulopathy 2024 Cugno, MassimoMancuso, Maria CristinaDepetri, FedericaPeyvandi, Flora + Article (author) -
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study 2024 Giannotta, Juri AlessandroMancini, IlariaAgosti, PasqualeTruma, AddolorataMiri, SynaPeyvandi, Flora + Article (author) -
Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging 2024 Gualtierotti, RobertaGiachi, AndreaTruma, AddolorataArcudi, SaraCiavarella, AlessandroBucciarelli, PaoloSiboni, Simona MariaPeyvandi, Flora + Article (author) -
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation 2024 Tripodi, ArmandoCapecchi, MarcoScalambrino, EricaClerici, MarigraziaScimeca, BarbaraAgosti, PasqualeBucciarelli, PaoloPeyvandi, Flora Article (author) -
Insights on the Development of PRACTICE, A Research-Oriented Healthcare Platform 2024 Ahmetovic, DraganAngileri, AlessioArcudi, SaraBettini, ClaudioCivitarese, GabrieleColussi, MarcoGiachi, AndreaGualtierotti, RobertaMascetti, SergioPeyvandi, FloraSolyman, AimanTruma, Addolorata + Book Part (author) -
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A 2024 Peyvandi, Flora + Article (author) -
Rare inherited coagulation disorders: no longer orphan and neglected 2024 Mohsenian, SaminMannucci, Pier MannuccioMenegatti, MarziaPeyvandi, Flora Article (author) -
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List 2024 Peyvandi, Flora + Article (author) -
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A 2024 Seidizadeh, OmidMollica, LucaBaronciani, LucianoPagliari, Maria TeresaCiavarella, AlessandroSiboni, Simona M.Peyvandi, Flora + Article (author) -
Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life 2024 Peyvandi, FloraGualtierotti, Roberta + Article (author) -
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura 2024 Peyvandi, Flora + Article (author) -